Danaher 3Q Sales, Profits Grow, Lifted by Covid-19 Work
October 21 2021 - 6:43AM
Dow Jones News
By Matt Grossman
Danaher Corp. on Thursday logged greater sales and earnings in
the third quarter, including contributions from its work on
Covid-19 testing and countermeasures.
The medical and diagnostics company posted earnings of $1.54 a
share, up from $1.16 a share a year earlier. Net income was $1.12
billion, up from $842 billion a year ago.
Stripping out one-time items, the company posted earnings of
$2.39 a share. Analysts were forecasting adjusted earnings of $2.15
a share, according to FactSet.
Danaher's sales were $7.23 billion, up from $5.88 billion in the
year-ago quarter. Analysts had anticipated revenue of $7
billion.
Covid-19-related tailwinds boosted sales by 10.5% in the
quarter. Excluding that and the effects of acquisitions and
currency exchange, base-business core sales growth was 10%
year-over-year, the company said.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 21, 2021 06:28 ET (10:28 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Danaher (NYSE:DHR)
Historical Stock Chart
From Sep 2023 to Sep 2024